-
Drug Pricing Differentials Across Therapy Areas in EU4, UK, and US
Mar 10, 2025, 14:00 PM -
A Framework for Evaluating the Economic and Operational Impact of Adopting the Sentimag®platform for Lesion Localization and Sentinel Lymph Node Biopsy in Women with Breast Cancer
Mar 10, 2025, 14:00 PM -
The Impact of Prior Choice for Between-Study Heterogeneity in Network Meta-Analysis on Model Conclusions
Mar 10, 2025, 14:00 PM -
Treatment Patterns in the Management of Vitiligo in a Colombian HMO During 2015-2023: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Is It Time to Rethink Proxy-Reporting? Feasibility and Psychometric Considerations for Creating ObsROs That Adhere to Patient-Focused Drug Development (PFDD) Fit-for-Purpose Guidance
Mar 10, 2025, 14:00 PM -
Exploring the Link Between Self-Efficacy and Medication Adherence: Psychometric Evaluation of the Traditional Chinese Beliefs About Medicines Questionnaire-Specific in Adults With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Characterizing the Burden and Drivers of Healthcare Utilization and Spending for Epilepsy and Seizures in the U.S., 2016-2022
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of the Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for disease prevention among Colombian Infants
Mar 10, 2025, 14:00 PM -
Real-World Patient Persistence and Adherence: A Comparison Of Long Acting Injectables and Oral Antipsychotics Used For The Treatment Of Schizophrenia in a Canadian Adult population
Mar 10, 2025, 14:00 PM -
Explore the Prognostic Factors of Survival Outcomes in Newly Diagnosed Multiple Myeloma Who Are Not Transplant Eligible
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of First-Line Tremelimumab Plus Durvalumab Versus Sorafenib in Unresectable Hepatocellular Carcinoma
Mar 10, 2025, 14:00 PM -
Quantifying Spillover Impacts: Effect of Novel Therapies for IgA Nephropathy on Patients Awaiting Kidney Transplant
Mar 10, 2025, 14:00 PM -
Chimeric Antigen Receptor T Cell (CAR T) Therapy As Second-Line (2L) Treatment for Patients With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Therapy Choice and Treatment Barriers Among US Oncologists
Mar 10, 2025, 14:00 PM -
A Budget Impact Analysis of Introducing OPSYNVI for the Treatment of Adult Patients Diagnosed With Pulmonary Arterial Hypertension
Mar 10, 2025, 14:00 PM -
Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA Discontinuation
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Chronic Lymphocytic Leukemia Treated with Fixed Duration Therapy in a First-Line Setting in Alberta, Canada
Mar 10, 2025, 14:00 PM -
An Assessment of Financial Burden and its Association with Desmoid Tumor Specific Symptoms and Impacts in Adult Desmoid Tumor Patients: Desmoid Tumor Research Foundation Natural History Study
Mar 10, 2025, 14:00 PM -
Demonstration of a Population-Level Biomarker Testing Economic Evaluation Tool for Oncology Interventions
Mar 10, 2025, 14:00 PM -
Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies
Mar 10, 2025, 14:00 PM -
Gaps In Screening Among Medicare Patients With A Ruptured Abdominal Aortic Aneurysm
Mar 10, 2025, 14:00 PM
